MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BS-181 dihydrochloride

CAS No. : 1883548-83-1

MCE 站：BS-181 dihydrochloride

产品活性：BS-181 dihydrochloride 是一种有效的，选择性的 CDK7 抑制剂 (IC₅₀=21 nM)，与 Seliciclib (HY-30237) 相比。BS-181 dihydrochloride 抑制 CDK2、CDK5 和 CDK9 的 IC₅₀ 值分别为 880 nM、3000 nM 和 4200 nM (不能阻断CDK1、4 和 6)。BS-181 dihydrochloride 抑制一组癌细胞生长 (IC₅₀=11.5 μM-37.3 μM)，诱导细胞凋亡 (apoptosis)。BS-181 dihydrochloride 可以用于癌症的相关研究。

研究领域：Cell Cycle/DNA Damage

作用靶点：CDK

In Vitro: BS-181 dihydrochloride (0-40 μM; 72 hours) inhibits cancer cells growth, it is against Breast cancer cell lines growth with IC₅₀ values ranging from 15.1 μM to 20 μM, it is against Colorectal cancer cell lines growth with IC₅₀ values ranging from 11.5 μM to15.3 μM and is against lung, osteosarcoma, prostate and liver cancer cell lines with IC₅₀ values ranging from 11.5 μM to 37.3 μM, respectively.
BS-181 dihydrochloride (0-50 μM; 4 hours) shows inhibition of phosphorylation of the RNA polymerase II C-terminal domain (CTD) at serine 5 (P-Ser5). It down-regulates CDK4 and cyclin D1 expression while does not effect other CDKs and cyclins.
BS-181 dihydrochloride (0-50 μM; 24 hours) shows an increase in cells in G1, accompanied by a reduction in cell numbers in S and G2/M at low concentrations. At higher concentrations, however, cells accumulates in the sub-G1, indicative of apoptosis.

In Vivo: BS-181 dihydrochloride (intraperitoneal injection; 10 mg/kg, 20 mg/kg; single dose) is well tolerated in mice without apparent weight altering.
BS-181 dihydrochloride (intraperitoneal injection; 5 mg/kg or 10 mg/kg twice daily; total daily doses of 10 mg/kg or 20 mg/kg; 14 days) inhibitstumor growth in a dose-dependent manner.?Tumor growth exhibits 25% and 50% reduction compared with the control group, for 10 mg/kg/day and 20 mg/kg/day, respectively.

相关产品：Ro-3306  |  Seliciclib  |  Flavopiridol  |  NVP-2  |  SNS-032  |  AZD-5438  |  Kenpaullone  |  GSK 3 Inhibitor IX  |  AUZ 454  |  XL413 hydrochloride  |  CGP60474  |  Wogonin  |  CVT-313  |  NG 52  |  BMS-265246  |  (R)-CR8 trihydrochloride  |  R547  |  PHA-767491 hydrochloride  |  CDK12-IN-3  |  KH-CB19  |  CDK2-IN-4  |  Purvalanol A  |  Cucurbitacin E  |  THZ1-R  |  FMF-04-159-2  |  LY2857785  |  CP-10  |  ML167

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。